Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein
- PMID: 9621082
- PMCID: PMC110424
- DOI: 10.1128/JVI.72.7.6159-6163.1998
Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein
Abstract
Exposure of Lipofectin-DNA complexes to the partially purified G glycoprotein of the vesicular stomatitis virus envelope (VSV-G) results in loss of serum-mediated inhibition and in enhanced efficiency of gene transfer. Sucrose density gradient sedimentation analysis indicated that the VSV-G associates physically with the DNA-lipid complex to produce a VSV-G liposome. The ability to incorporate surrogate viral or cellular envelope components such as VSV-G into liposomes may allow more-efficient and possibly targeted gene delivery by lipofection, both in vitro and in vivo.
Figures




Similar articles
-
VSV-G envelope glycoprotein forms complexes with plasmid DNA and MLV retrovirus-like particles in cell-free conditions and enhances DNA transfection.Mol Ther. 2001 Sep;4(3):232-8. doi: 10.1006/mthe.2001.0443. Mol Ther. 2001. PMID: 11545614
-
Preparation of virosomes coated with the vesicular stomatitis virus glycoprotein as efficient gene transfer vehicles for animal cells.Microbiol Immunol. 2004;48(3):163-74. doi: 10.1111/j.1348-0421.2004.tb03502.x. Microbiol Immunol. 2004. PMID: 15031529
-
Preparation of vesicular stomatitis virus-G (VSV-G) conjugate and its use in gene transfer.Cold Spring Harb Protoc. 2012 Apr 1;2012(4):453-6. doi: 10.1101/pdb.prot068528. Cold Spring Harb Protoc. 2012. PMID: 22474657
-
A novel nonviral vector based on vesicular stomatitis virus.J Control Release. 2000 Aug 10;68(2):187-94. doi: 10.1016/s0168-3659(00)00250-9. J Control Release. 2000. PMID: 10925127
-
Emerging Biomedical Applications of the Vesicular Stomatitis Virus Glycoprotein.ACS Omega. 2022 Sep 6;7(37):32840-32848. doi: 10.1021/acsomega.2c03517. eCollection 2022 Sep 20. ACS Omega. 2022. PMID: 36157773 Free PMC article. Review.
Cited by
-
In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein.J Virol. 1998 Aug;72(8):6356-61. doi: 10.1128/JVI.72.8.6356-6361.1998. J Virol. 1998. PMID: 9658075 Free PMC article.
-
Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles.Bioeng Transl Med. 2021 Mar 20;6(2):e10213. doi: 10.1002/btm2.10213. eCollection 2021 May. Bioeng Transl Med. 2021. PMID: 33786376 Free PMC article. Review.
-
Targeting the Inside of Cells with Biologicals: Chemicals as a Delivery Strategy.BioDrugs. 2021 Nov;35(6):643-671. doi: 10.1007/s40259-021-00500-y. Epub 2021 Oct 27. BioDrugs. 2021. PMID: 34705260 Free PMC article. Review.
-
Axonal degeneration is blocked by nicotinamide mononucleotide adenylyltransferase (Nmnat) protein transduction into transected axons.J Biol Chem. 2010 Dec 31;285(53):41211-5. doi: 10.1074/jbc.C110.193904. Epub 2010 Nov 11. J Biol Chem. 2010. PMID: 21071441 Free PMC article.
-
Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy.J Vis Exp. 2017 May 18;(123):55741. doi: 10.3791/55741. J Vis Exp. 2017. PMID: 28570530 Free PMC article.
References
-
- Abe A, Emi N, Taji H, Kasai M, Kohno A, Saito H. Induction of humoral and cellular anti-idiotypic immunity by intradermal injection of naked DNA encoding a human variable region gene sequence of an immunoglobulin heavy chain in a B cell malignancy. Gene Ther. 1996;3:988–993. - PubMed
-
- Abe, A., S.-T. Chen, A. Miyanohara, and T. Friedmann. Submitted for publication.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources